The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...
The biopharmaceutical and biotech industries face mounting challenges in regulated environments, including rising drug development costs, strict regulatory demands, and the need for scalable, ...
MEDFORD, Mass.--(BUSINESS WIRE)--Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today ...
Single-use systems could run perfusion cultures and help biopharma intensify production, but understanding the potential process risks is critical, according to new research. Perfusion cultures—in ...
Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...
Erbi's differentiated 2 ml micro-bioreactor platform technology, Breez ™, enables rapid lab testing for bioprocessing scale up Allows MilliporeSigma to offer full range of bioreactors, from 2ml to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results